Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Haematopoietic stem cell transplantation in CSF1R-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.

Mochel F, Delorme C, Czernecki V, Froger J, Cormier F, Ellie E, Fegueux N, Lehéricy S, Lumbroso S, Schiffmann R, Aubourg P, Roze E, Labauge P, Nguyen S.

J Neurol Neurosurg Psychiatry. 2019 Jun 18. pii: jnnp-2019-320701. doi: 10.1136/jnnp-2019-320701. [Epub ahead of print] No abstract available.

PMID:
31213485
2.

Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation.

Lau B, Meier N, Serra G, Czernecki V, Schuepbach M, Navarro S, Cornu P, Grabli D, Agid Y, Vidailhet M, Karachi C, Welter ML.

Neurology. 2019 May 28;92(22):e2559-e2570. doi: 10.1212/WNL.0000000000007562. Epub 2019 May 1.

3.

Long-term effects of subthalamic stimulation in Obsessive-Compulsive Disorder: Follow-up of a randomized controlled trial.

Mallet L, Du Montcel ST, Clair AH, Arbus C, Bardinet E, Baup N, Chabardès S, Chéreau I, Czernecki V, Fontaine D, Harika-Germaneau G, Haynes WI, Houeto JL, Jaafari N, Krack P, Millet B, Navarro S, Polosan M, Pelissolo A, Welter ML; STOC Long-term Study Group.

Brain Stimul. 2019 Jul - Aug;12(4):1080-1082. doi: 10.1016/j.brs.2019.04.004. Epub 2019 Apr 9. No abstract available.

PMID:
30992192
4.

Dysexecutive disorders and their diagnosis: A position paper.

Godefroy O, Martinaud O, Narme P, Joseph PA, Mosca C, Lhommée E, Meulemans T, Czernecki V, Bertola C, Labauge P, Verny M, Bellmann A, Azouvi P, Bindschaedler C, Bretault E, Boutoleau-Bretonniere C, Robert P, Lenoir H, Krier M, Roussel M; GREFEX study group.

Cortex. 2018 Dec;109:322-335. doi: 10.1016/j.cortex.2018.09.026. Epub 2018 Oct 17. Review.

PMID:
30415091
5.

Disentangling Tourette syndrome heterogeneity through hierarchical ascendant clustering.

Cravedi E, Deniau E, Giannitelli M, Pellerin H, Czernecki V, Priou T, Xavier J, Consoli A, Hartmann A, Cohen D.

Dev Med Child Neurol. 2018 Sep;60(9):942-950. doi: 10.1111/dmcn.13913. Epub 2018 May 10.

6.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
7.

Health-Related Quality of Life Is Severely Affected in Primary Orthostatic Tremor.

Maugest L, McGovern EM, Mazalovic K, Doulazmi M, Apartis E, Anheim M, Bourdain F, Benchetrit E, Czernecki V, Broussolle E, Bonnet C, Falissard B, Jahanshahi M, Vidailhet M, Roze E.

Front Neurol. 2018 Jan 15;8:747. doi: 10.3389/fneur.2017.00747. eCollection 2017.

8.

Personality and Neuropsychological Profiles in Friedreich Ataxia.

Sayah S, Rotgé JY, Francisque H, Gargiulo M, Czernecki V, Justo D, Lahlou-Laforet K, Hahn V, Pandolfo M, Pelissolo A, Fossati P, Durr A.

Cerebellum. 2018 Apr;17(2):204-212. doi: 10.1007/s12311-017-0890-5.

PMID:
29086357
9.

Pedunculopontine nucleus deep brain stimulation in Parkinson's disease: A clinical review.

Thevathasan W, Debu B, Aziz T, Bloem BR, Blahak C, Butson C, Czernecki V, Foltynie T, Fraix V, Grabli D, Joint C, Lozano AM, Okun MS, Ostrem J, Pavese N, Schrader C, Tai CH, Krauss JK, Moro E; Movement Disorders Society PPN DBS Working Groupin collaboration with the World Society for Stereotactic and Functional Neurosurgery.

Mov Disord. 2018 Jan;33(1):10-20. doi: 10.1002/mds.27098. Epub 2017 Sep 28. Review.

PMID:
28960543
10.

Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial.

Welter ML, Houeto JL, Thobois S, Bataille B, Guenot M, Worbe Y, Hartmann A, Czernecki V, Bardinet E, Yelnik J, du Montcel ST, Agid Y, Vidailhet M, Cornu P, Tanguy A, Ansquer S, Jaafari N, Poulet E, Serra G, Burbaud P, Cuny E, Aouizerate B, Pollak P, Chabardes S, Polosan M, Borg M, Fontaine D, Giordana B, Raoul S, Rouaud T, Sauvaget A, Jalenques I, Karachi C, Mallet L; STIC study group.

Lancet Neurol. 2017 Aug;16(8):610-619. doi: 10.1016/S1474-4422(17)30160-6. Epub 2017 Jun 20.

PMID:
28645853
11.

Dysexecutive syndrome in Parkinson's disease: the GREFEX study.

Roussel M, Lhommée E, Narme P, Czernecki V, Gall DL, Krystkowiak P, Diouf M, Godefroy O; GREFEX study group.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Sep;24(5):496-507. doi: 10.1080/13825585.2016.1226248. Epub 2016 Sep 1.

PMID:
27585478
12.

French consensus procedure for assessing cognitive function in Parkinson's disease.

Dujardin K, Auzou N, Lhommée E, Czernecki V, Dubois B, Fradet A, Maltete D, Meyer M, Pineau F, Schmitt E, Sellal F, Tison F, Vidal T, Azulay JP, Welter ML, Corvol JC, Durif F, Rascol O; NS-Park network.

Rev Neurol (Paris). 2016 Nov;172(11):696-702. doi: 10.1016/j.neurol.2016.05.001. Epub 2016 Jun 16.

PMID:
27318613
13.

Executive functioning and risk-taking behavior in Parkinson's disease patients with impulse control disorders.

Pineau F, Roze E, Lacomblez L, Bonnet AM, Vidailhet M, Czernecki V, Corvol JC.

J Neural Transm (Vienna). 2016 Jun;123(6):573-81. doi: 10.1007/s00702-016-1549-y. Epub 2016 Apr 16.

PMID:
27085342
14.

Impact of Perceived Stress, Anxiety-Depression and Social Support on Coping Strategies of Parents Having A Child With Gilles de la Tourette Syndrome.

Goussé V, Czernecki V, Denis P, Stilgenbauer JL, Deniau E, Hartmann A.

Arch Psychiatr Nurs. 2016 Feb;30(1):109-13. doi: 10.1016/j.apnu.2015.08.017. Epub 2015 Aug 29.

PMID:
26804511
15.

PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study.

Welter ML, Demain A, Ewenczyk C, Czernecki V, Lau B, El Helou A, Belaid H, Yelnik J, François C, Bardinet E, Karachi C, Grabli D.

J Neurol. 2015 Jun;262(6):1515-25. doi: 10.1007/s00415-015-7744-1. Epub 2015 Apr 23.

PMID:
25904205
16.

Dopaminergic modulation of emotional conflict in Parkinson's disease.

Fleury V, Cousin E, Czernecki V, Schmitt E, Lhommée E, Poncet A, Fraix V, Troprès I, Pollak P, Krainik A, Krack P.

Front Aging Neurosci. 2014 Jul 23;6:164. doi: 10.3389/fnagi.2014.00164. eCollection 2014.

17.

Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing.

Barton BR, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG.

Mov Disord. 2014 Sep;29(10):1252-7. doi: 10.1002/mds.25902. Epub 2014 May 13.

PMID:
24821679
18.

Optimal target localization for subthalamic stimulation in patients with Parkinson disease.

Welter ML, Schüpbach M, Czernecki V, Karachi C, Fernandez-Vidal S, Golmard JL, Serra G, Navarro S, Welaratne A, Hartmann A, Mesnage V, Pineau F, Cornu P, Pidoux B, Worbe Y, Zikos P, Grabli D, Galanaud D, Bonnet AM, Belaid H, Dormont D, Vidailhet M, Mallet L, Houeto JL, Bardinet E, Yelnik J, Agid Y.

Neurology. 2014 Apr 15;82(15):1352-61. doi: 10.1212/WNL.0000000000000315. Epub 2014 Mar 19.

19.

Can we still dream when the mind is blank? Sleep and dream mentations in auto-activation deficit.

Leu-Semenescu S, Uguccioni G, Golmard JL, Czernecki V, Yelnik J, Dubois B, Forgeot d'Arc B, Grabli D, Levy R, Arnulf I.

Brain. 2013 Oct;136(Pt 10):3076-84. doi: 10.1093/brain/awt229. Epub 2013 Sep 11.

PMID:
24026624
20.

[Non-motor symptoms in Parkinson's disease: cognition and behavior].

Bonnet AM, Czernecki V.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Sep;11(3):295-304. doi: 10.1684/pnv.2013.0423. Review. French.

PMID:
24026132
21.

Long-term white matter changes after severe traumatic brain injury: a 5-year prospective cohort.

Dinkel J, Drier A, Khalilzadeh O, Perlbarg V, Czernecki V, Gupta R, Gomas F, Sanchez P, Dormont D, Galanaud D, Stevens RD, Puybasset L; for NICER (Neuro Imaging for Coma Emergence and Recovery) Consortium.

AJNR Am J Neuroradiol. 2014 Jan;35(1):23-9. doi: 10.3174/ajnr.A3616. Epub 2013 Jul 11.

22.

Critical roles for anterior insula and dorsal striatum in punishment-based avoidance learning.

Palminteri S, Justo D, Jauffret C, Pavlicek B, Dauta A, Delmaire C, Czernecki V, Karachi C, Capelle L, Durr A, Pessiglione M.

Neuron. 2012 Dec 6;76(5):998-1009. doi: 10.1016/j.neuron.2012.10.017.

23.

Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects.

Bonnet AM, Jutras MF, Czernecki V, Corvol JC, Vidailhet M.

Parkinsons Dis. 2012;2012:198316. doi: 10.1155/2012/198316. Epub 2012 Jul 25.

24.

Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.

Barton B, Grabli D, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG.

Mov Disord. 2012 Feb;27(2):248-53. doi: 10.1002/mds.24059. Epub 2011 Dec 9.

PMID:
22162144
25.

Neuropsychological, neuropsychiatric, and quality of life issues in DBS for dystonia.

Jahanshahi M, Czernecki V, Zurowski AM.

Mov Disord. 2011 Jun;26 Suppl 1:S63-78. doi: 10.1002/mds.23511. Review.

PMID:
21692114
26.

European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment.

Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, Czernecki V, Robertson MM, Martino D, Munchau A, Rizzo R; ESSTS Guidelines Group.

Eur Child Adolesc Psychiatry. 2011 Apr;20(4):155-71. doi: 10.1007/s00787-011-0164-6. Erratum in: Eur Child Adolesc Psychiatry. 2011 Jul;20(7):377.

27.

Motor tic of the neck: a probable cause of stroke in a child with Gilles de la Tourette syndrome.

van Meerbeeck P, Behar C, Czernecki V, Roze E, Deniau E, Hartmann A.

Mov Disord. 2011 Apr;26(5):928-9. doi: 10.1002/mds.23521. Epub 2011 Mar 2. No abstract available.

PMID:
21370260
28.

Poor creativity in frontotemporal dementia: a window into the neural bases of the creative mind.

de Souza LC, Volle E, Bertoux M, Czernecki V, Funkiewiez A, Allali G, Leroy B, Sarazin M, Habert MO, Dubois B, Kas A, Levy R.

Neuropsychologia. 2010 Nov;48(13):3733-42. doi: 10.1016/j.neuropsychologia.2010.09.010. Epub 2010 Sep 22.

PMID:
20868703
29.

Myoclonus dystonia plus syndrome due to a novel 7q21 microdeletion.

Saugier-Veber P, Doummar D, Barthez MA, Czernecki V, Drouot N, Apartis E, Bürglen L, Frebourg T, Roze E.

Am J Med Genet A. 2010 May;152A(5):1244-9. doi: 10.1002/ajmg.a.33369.

PMID:
20425829
30.

Subacute dopa-responsive Parkinsonism after successful surgical treatment of aqueductal stenosis.

Kinugawa K, Itti E, Lepeintre JF, Mari I, Czernecki V, Heran F, Clemenceau S, Vidailhet M, Roze E.

Mov Disord. 2009 Dec 15;24(16):2438-40. doi: 10.1002/mds.22862. No abstract available.

PMID:
19908324
31.

Segmental progression of early untreated Parkinson's disease: a novel approach to clinical rating.

Schüpbach WM, Corvol JC, Czernecki V, Djebara MB, Golmard JL, Agid Y, Hartmann A.

J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):20-5. doi: 10.1136/jnnp.2008.159699. Epub 2009 Jul 20.

PMID:
19622523
32.

Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study.

Vidailhet M, Yelnik J, Lagrange C, Fraix V, Grabli D, Thobois S, Burbaud P, Welter ML, Xie-Brustolin J, Braga MC, Ardouin C, Czernecki V, Klinger H, Chabardes S, Seigneuret E, Mertens P, Cuny E, Navarro S, Cornu P, Benabid AL, Le Bas JF, Dormont D, Hermier M, Dujardin K, Blond S, Krystkowiak P, Destée A, Bardinet E, Agid Y, Krack P, Broussolle E, Pollak P; French SPIDY-2 Study Group.

Lancet Neurol. 2009 Aug;8(8):709-17. doi: 10.1016/S1474-4422(09)70151-6. Epub 2009 Jul 1.

PMID:
19576854
33.

The Emotional Stroop task: a comparison between schizophrenic subjects and controls.

Demily C, Attala N, Fouldrin G, Czernecki V, Ménard JF, Lamy S, Dubois B, Thibaut F.

Eur Psychiatry. 2010 Mar;25(2):75-9. doi: 10.1016/j.eurpsy.2009.02.003. Epub 2009 Jun 21.

PMID:
19541456
34.

Apathy: a major symptom in CADASIL.

Reyes S, Viswanathan A, Godin O, Dufouil C, Benisty S, Hernandez K, Kurtz A, Jouvent E, O'Sullivan M, Czernecki V, Bousser MG, Dichgans M, Chabriat H.

Neurology. 2009 Mar 10;72(10):905-10. doi: 10.1212/01.wnl.0000344166.03470.f8.

PMID:
19273824
35.

Subthalamic nucleus stimulation in severe obsessive-compulsive disorder.

Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, du Montcel ST, Yelnik J, Chéreau I, Arbus C, Raoul S, Aouizerate B, Damier P, Chabardès S, Czernecki V, Ardouin C, Krebs MO, Bardinet E, Chaynes P, Burbaud P, Cornu P, Derost P, Bougerol T, Bataille B, Mattei V, Dormont D, Devaux B, Vérin M, Houeto JL, Pollak P, Benabid AL, Agid Y, Krack P, Millet B, Pelissolo A; STOC Study Group.

N Engl J Med. 2008 Nov 13;359(20):2121-34. doi: 10.1056/NEJMoa0708514. Erratum in: N Engl J Med. 2009 Sep 3;361(10):1027.

36.

Internal pallidal and thalamic stimulation in patients with Tourette syndrome.

Welter ML, Mallet L, Houeto JL, Karachi C, Czernecki V, Cornu P, Navarro S, Pidoux B, Dormont D, Bardinet E, Yelnik J, Damier P, Agid Y.

Arch Neurol. 2008 Jul;65(7):952-7. doi: 10.1001/archneur.65.7.952.

PMID:
18625864
37.

Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom.

Czernecki V, Schüpbach M, Yaici S, Lévy R, Bardinet E, Yelnik J, Dubois B, Agid Y.

Mov Disord. 2008 May 15;23(7):964-969. doi: 10.1002/mds.21949.

PMID:
18398913
38.

Disconnecting force from money: effects of basal ganglia damage on incentive motivation.

Schmidt L, d'Arc BF, Lafargue G, Galanaud D, Czernecki V, Grabli D, Schüpbach M, Hartmann A, Lévy R, Dubois B, Pessiglione M.

Brain. 2008 May;131(Pt 5):1303-10. doi: 10.1093/brain/awn045. Epub 2008 Mar 15.

PMID:
18344560
39.

Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior.

Mallet L, Schüpbach M, N'Diaye K, Remy P, Bardinet E, Czernecki V, Welter ML, Pelissolo A, Ruberg M, Agid Y, Yelnik J.

Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10661-6. Epub 2007 Jun 7.

40.

Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial.

Schüpbach WM, Maltête D, Houeto JL, du Montcel ST, Mallet L, Welter ML, Gargiulo M, Béhar C, Bonnet AM, Czernecki V, Pidoux B, Navarro S, Dormont D, Cornu P, Agid Y.

Neurology. 2007 Jan 23;68(4):267-71. Epub 2006 Dec 6.

PMID:
17151341
41.

Apathy and the basal ganglia.

Levy R, Czernecki V.

J Neurol. 2006 Dec;253 Suppl 7:VII54-61. Review.

PMID:
17131230
42.

Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.

Schüpbach M, Lohmann E, Anheim M, Lesage S, Czernecki V, Yaici S, Worbe Y, Charles P, Welter ML, Pollak P, Dürr A, Agid Y, Brice A.

Mov Disord. 2007 Jan;22(1):119-22.

PMID:
17080443
43.

Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.

Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, Hosseini H, Pelissolo A, Moro E, Lhommée E, Lang AE, Agid Y, Benabid AL, Pollak P, Mallet L, Krack P.

Mov Disord. 2006 Nov;21(11):1941-6.

PMID:
16972268
44.

An effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution.

Pessiglione M, Czernecki V, Pillon B, Dubois B, Schüpbach M, Agid Y, Tremblay L.

J Cogn Neurosci. 2005 Dec;17(12):1886-96.

PMID:
16356326
45.

Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.

Schüpbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM, Czernecki V, Maltête D, Hartmann A, Mallet L, Pidoux B, Dormont D, Navarro S, Cornu P, Mallet A, Agid Y.

J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1640-4.

46.

Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?

Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y, Dubois B.

J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):775-9.

47.

Dopamine and cognitive function.

Pillon B, Czernecki V, Dubois B.

Curr Opin Neurol. 2003 Dec;16 Suppl 2:S17-22. Review.

PMID:
15129846
48.

[Dysexecutive syndromes and degenerative diseases].

Pillon B, Czernecki V, Dubois B.

Rev Neurol (Paris). 2004 Apr;160(4 Pt 2):S24-30. Review. French.

PMID:
15118550
49.

Motivation, reward, and Parkinson's disease: influence of dopatherapy.

Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B.

Neuropsychologia. 2002;40(13):2257-67.

PMID:
12417456

Supplemental Content

Loading ...
Support Center